www.sequenovasolutions.com
FASTASeq 300
Introduction:
FASTASeq 300 by GeneMind is a cutting-edge next-generation sequencing (NGS) platform designed for fast and accurate genomic analysis. It enables comprehensive DNA and RNA sequencing with a focus on high throughput and precision.Technology:
FASTASeq 300 uses advanced sequencing by synthesis (SBS) technology, leveraging a combination of high-density arrays and parallel processing to read millions of DNA fragments simultaneously, achieving faster results.Advantages:
It offers superior accuracy, reduced sequencing time, cost-effectiveness, and scalability, with minimal sample input requirements and high-quality data output for diverse genomic research.Applications:
FASTASeq 300 is widely applied in genomics, transcriptomics, Metagenomics, personalized medicine, cancer research, and microbiome analysis, facilitating breakthroughs in diagnostics and treatment strategies.Impact:
The platform's efficiency and precision accelerate genomic discovery, leading to faster medical research, improved diagnostics, and personalized therapeutic approaches across diverse healthcare fields.

FCM : 100 Million reads / Flow cell Output upto 30GB
FCH : 250 Million reads / Flow cell Output upto 75 GB






GenoLab M
Introduction:
GenoLab M by GeneMind is an advanced molecular diagnostics platform designed to perform high-throughput genetic analysis with a focus on precision and accuracy for clinical and research purposes.Technology:
GenoLab M integrates cutting-edge next-generation sequencing (NGS) and microarray technology, offering robust data collection and real-time analysis for a wide range of genetic markers and mutations.Advantages:
It provides fast turnaround times, high sensitivity, low error rates, and the ability to analyze complex genetic data with minimal sample requirements, making it cost-effective and reliable.Applications:
GenoLab M is used in clinical diagnostics, personalized medicine, genetic screening, cancer research, and rare disease detection, enabling precise treatment planning and patient management.Impact:
The platform drives advancements in personalized healthcare, offering actionable genetic insights that improve patient outcomes, streamline diagnostics, and foster innovations in therapeutic development.


FCM : 250 Million reads / Flow cell Output upto 75 GB
FCH : 500 Million reads / Flow cell Output upto 150 GB






SURFSeq 5000
The SURFSeq 5000 is a high-throughput sequencing platform that leverages "Surface Enhanced Fluorescence" technology. This method uses a specialized surface to enhance the detection of fluorescent signals during DNA sequencing, allowing for faster and more accurate reading of nucleotide sequences.
Technology:
It utilizes a novel optical detection system combined with fluorescently labeled nucleotides and high-resolution imaging to read DNA fragments in real time. The platform's surface enhancement improves the signal intensity, providing better sensitivity and reduced error rates compared to traditional sequencing methods.Advantages:
Higher Sensitivity: The enhanced fluorescence system provides a stronger signal, increasing sequencing accuracy and throughput.
Faster Results: The technology enables faster sequencing with reduced cycle times, making it ideal for large-scale genomic projects.
Reduced Errors: The precision in detection minimizes sequencing errors, improving data quality.
Applications:
Genomic Research:
Clinical Diagnostics:
Microbial and Environmental Sequencing:
Impact:
The SURFSeq 5000's advanced sequencing capabilities allow for more comprehensive genomic analysis at a reduced cost and faster turnaround time, supporting a wide range of biological and medical research applications.

FCM : 500 Million reads / Flow cell Output upto 150 GB
FCH : 2000 Million reads / Flow cell Output upto 600 GB






Introduction:
SURFSeq Q by GeneMind is an advanced sequencing platform designed for high-quality, rapid genomic analysis, specializing in both DNA and RNA sequencing for comprehensive research and clinical applications.Technology:
It utilizes a unique sequencing technology that combines single-cell RNA sequencing with high-resolution genomic profiling, offering deep insights into gene expression and genetic variations with high throughput.Advantages:
SURFSeq Q delivers exceptional precision, fast data processing, scalable throughput, and minimal sample requirements, providing cost-effective solutions for high-complexity genomic studies.Applications:
The platform is applied in personalized medicine, cancer genomics, gene expression analysis, rare disease diagnostics, and biomarker discovery, enabling better-targeted treatments and therapies.Impact:
SURFSeq Q enhances the speed and accuracy of genomic research, accelerating discoveries in healthcare, advancing precision medicine, and improving patient outcomes through targeted therapeutic strategies.

FCM : 11.7 Billion reads / Flow cell Output upto 3.5 TB
FCH : 23.3 Billion reads / Flow cell Output upto 7 TB
SURFSeq Q : -






MrLH 96 Dx : -
MrLH-96 automated workstation is designed for the efficient automation of high-throughput acid extraction and NGS library preparation and laboratory liquid processing procedure.
With the principle of Air replacement of MrLH 96 DX, the specially designed consumable stacking system is able to guarantee full automation with no manpower on site.
The Inheco temperature-controlled oscillation accessories not only ensure the stability of the oscillation but also have the accuracy of temperature control within the range of 4~70°C, which perfectly matches the NGS hybridization capture process.
The script design system can be used to explore multiple applications and customize the workflow design.
Product advantages includes Highly automated less Manpower is needed, Easy to connect with LIMS system, Compatible with Inheco Temperature control Module.
Applications Include : -




Genoscout EM:-
The Automated Nucleic Acid Extractor (GenoScout EM) is a high-throughput, high-precision device designed for nucleic acid extraction.
It is paired with pre-packaged extraction reagents based on superparamagnetic silica-coated magnetic beads, This enables the extraction and purification of nucleic acids from a variety of biological samples, including blood, tissue, cells, body fluids, bacteria and viruses.
The system realizes the purification and enrichment of nucleic acid through the adsorption, transfer, and release of magnetic beads by magnetic rods.
Characterized by rapid and user-friendly operation with a high level of automation, the system is widely applicable in the fields of molecular diagnostics and animal disease detection.
The system is equipped with built-in UV sterilization and a HEPA fltration system to reduce the risk of contamination, and the shut-down time is customizable.

